Participated · Equity · Jun 2026

Founded by economist Leonardo Bursztyn and launched in 2024, Nomo offers a gamified mobile platform that encourages reduced social-media use through collective incentives, competitions, and individual rewards. The app emphasizes social approaches rather than blocking, featuring mechanics like the popular "soquinho" that temporarily locks social apps and awards points; in the first two schools in Rio de Janeiro the feature registered 40,000 soquinhos in a week. Nomo has users in more than 50 countries and has grown largely via institutional partnerships, including a Rio de Janeiro municipal program set to expand to about 500 schools by August and a U.K. program expanding to 52 schools. Early adoption metrics include 88% voluntary participation among students in the first week of the Rio deployments. The startup is testing additional markets in the U.S. and U.K. and is developing a program for older adults in the U.S. in partnership with a wearable health device maker. The company's funding and partnerships include academic- and medical-linked investors, which the founder cites as validation for its mental-health thesis.

Participated · Seed · Apr 2026

CavilinQ is developing cavity-enhanced photonic links that aim to connect individual quantum processors into unified, modular clusters to enable larger-scale quantum computing. The platform is described as hardware-agnostic, with initial demonstrations planned for integration with neutral atom quantum processors. Its technology builds on high-fidelity light-matter interfaces advanced by scientific co-founders Mikhail Lukin and Hannes Bernien. The company plans to establish a specialized laboratory in Cambridge, Massachusetts, expand its team, and reach key technical milestones. CavilinQ announced a completed $8.8 million seed round to fund these efforts. The company positions its interconnects as enabling distributed quantum architectures that could scale performance and reliability beyond isolated processors.

Participated · Seed · Mar 2026

Theta Neurotech is developing a non-invasive wearable EEG patch aimed at forecasting seizures. The company pivoted from a broader consumer "Fitbit for the brain" concept toward a medical wedge focused on epilepsy after identifying clinical demand and behavioral considerations for EEG wearables. Theta has raised $2 million in pre-seed funding to support device development, machine-learning research, and an exploratory clinical study. Co-founders Truman Pierson and Christopher Fitz lead the company. The market for seizure monitoring includes invasive and non-invasive competitors, but non-invasive seizure forecasting remains early-stage and challenging. Several rivals are running exploratory studies, and none have yet reached patients.

Participated · Seed · Mar 2025

SimCare AI offers an AI-driven healthcare simulation platform that creates realistic, dynamic AI patients whose decision trees map each interaction to accreditation standards. The system enables institutions to track, assess, and verify student competencies, allowing practice and evaluation anytime, anywhere. By standardizing scenarios the platform reduces faculty burden and training costs while accelerating the pace at which new clinicians can enter the workforce. Its platform can be customized for different specialties and use cases, from residency programs to social work training, and is used by telehealth companies for screening and onboarding. SimCare AI has already closed 30 pilots with institutions including the University of Pennsylvania. The company plans to use new funding to expand operations and continue product development.